HDAC9 and cancer: The HDAC inhibitors—phenyl butyrate,13 sodium butyrate,14 TSA (trichostatin A),15, 16, 17 SAHA (suberoylanilide hydroxamic acid),17, 18, 19 M344,17 depsipeptide,17 and a benzamide MS‐27520 have shown tumor cell radiosensitivity in various cancer cell lines.